Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02974621
Brief Title: Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma

First Submitted : November 23, 2016
First Submitted that Met QC Criteria : November 23, 2016
First Posted : November 28, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 8, 2021
Last Update Posted : June 9, 2021